Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
A photo of Professor Sir Peter Ratcliffe with the members of his research group, posing outside the NDM Research Building on a sunny day

Professor Sir Peter Ratcliffe

Our laboratory is studying the role of hypoxia and related metabolic stresses in driving aggressive cancer phenotypes. A specific focus is on the role of transcriptional cascades mediated by hypoxia inducible factors (HIFs). These pathways are almost universally activated in cancer, both by micro-environmental hypoxia and by direct connections to oncogene and tumour suppressors.

We are interested in both hypoxia signalling pathways themselves, and in the general implications of activating very extensive interconnected signalling pathways during cancer development. A particular focus of our work is on understanding how multiple pro- and anti-tumorigenic effects of hypoxia pathway ‘switching’ are accommodated during cancer development, including how these processes drive tumour heterogeneity, chaotic cancer cell biology, and resistance to treatment.


Find out more about research in the Ratcliffe lab.

Our team